Published online November 1, 2006
PEDIATRICS Vol. 118 No. 5 November 2006, pp. 1950-1961 (doi:10.1542/10.1542/peds.2006-0841)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pappa, H. M.
Right arrow Articles by Grand, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pappa, H. M.
Right arrow Articles by Grand, R. J.
Related Collections
Right arrow Nutrition & Metabolism
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Vitamin D Status in Children and Young Adults With Inflammatory Bowel Disease

Helen M. Pappa, MD, MPHa, Catherine M. Gordon, MD, MScb, Tracee M. Saslowsky, MSN, PNPa, Anna Zholudev, MPHa, Brian Horr, BAa, Mei-Chiung Shih, PhDc and Richard J. Grand, MDa

a Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition
b Division of Endocrinology and Adolescent Medicine
c Clinical Research Program, Children’s Hospital Boston, Boston, Massachusetts

OBJECTIVES. Previous studies of vitamin D status in pediatric patients with inflammatory bowel disease have revealed conflicting results. We sought to report (1) the prevalence of vitamin D deficiency (serum 25-hydroxy-vitamin D concentration ≤15 ng/mL) in a large population with inflammatory bowel disease, (2) factors predisposing to this problem, and (3) its relationship to bone health and serum parathyroid hormone concentration.

PATIENTS AND METHODS. A total of 130 patients (8–22 years of age) with inflammatory bowel disease, 94 with Crohn disease and 36 with ulcerative colitis, had serum 25-hydroxy-vitamin D, intact parathyroid hormone, and lumbar spine bone mineral density (using dual-energy x-ray absorptiometry) measured at Children’s Hospital Boston.

RESULTS. The prevalence of vitamin D deficiency was 34.6%. Mean serum 25-hydroxy-vitamin D concentration was similar in patients with Crohn disease and ulcerative colitis, 52.6% lower among patients with dark skin complexion, 33.4% lower during the winter months (December 22 to March 21), and 31.5% higher among patients who were taking vitamin D supplements. Serum 25-hydroxy-vitamin D concentration was positively correlated with weight and BMI z score, disease duration, and serum albumin concentration and negatively correlated with erythrocyte sedimentation rate. Patients with Crohn disease and upper gastrointestinal tract involvement were more likely to be vitamin D deficient than those without it. Serum 25-hydroxy-vitamin concentration was not associated with lumbar spine bone mineral density z score or serum parathyroid hormone concentration.

CONCLUSIONS. Vitamin D deficiency is highly prevalent among pediatric patients with inflammatory bowel disease. Factors predisposing to the problem include having a dark-skin complexion, winter season, lack of vitamin D supplementation, early stage of disease, more severe disease, and upper gastrointestinal tract involvement in patients with Crohn disease. The long-term significance of hypovitaminosis D for this population is unknown at present and merits additional study.


Key Words: vitamin D deficiency • 25-hydroxy-vitamin D • inflammatory bowel disease • pediatric • bone mineral density • parathyroid hormone

Abbreviations: 25OHD—25-hydroxy-vitamin D • BMD—bone mineral density • IBD—inflammatory bowel disease • CD—Crohn disease • UC—ulcerative colitis • UGI—upper gastrointestinal tract • LSBMD—lumbar spine bone mineral density • PTH—parathyroid hormone • ESR—erythrocyte sedimentation rate • DXA—dual-energy x-ray absorptiometry • GCRC—General Clinical Research Center • zLSBMD—z score of lumbar spine bone mineral density • zWt—z score of weight • zHt—z score of height • zBMI—z score of BMI • OR—odds ratio • CI—confidence interval • DBP—vitamin D–binding protein


Accepted Jun 22, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Liu, L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison
Altered Endocrine and Autocrine Metabolism of Vitamin D in a Mouse Model of Gastrointestinal Inflammation
Endocrinology, October 1, 2008; 149(10): 4799 - 4808.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. C. McCann and B. N. Ames
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
FASEB J, April 1, 2008; 22(4): 982 - 1001.
[Abstract] [Full Text] [PDF]